Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 22, 2021

SELL
$17.48 - $25.46 $17,480 - $25,460
-1,000 Closed
0 $0
Q1 2021

Apr 12, 2021

BUY
$18.08 - $28.8 $18,080 - $28,800
1,000 New
1,000 $23,000
Q3 2020

Oct 28, 2020

SELL
$11.21 - $13.82 $2,197 - $2,708
-196 Closed
0 $0
Q1 2020

Apr 13, 2020

SELL
$8.78 - $18.6 $465 - $985
-53 Reduced 21.29%
196 $2,000
Q3 2019

Oct 15, 2019

BUY
$12.75 - $19.01 $675 - $1,007
53 Added 27.04%
249 $3,000
Q1 2019

Apr 12, 2019

SELL
$15.53 - $22.15 $434 - $620
-28 Reduced 12.5%
196 $4,000
Q3 2018

Nov 01, 2018

SELL
$13.35 - $19.1 $734 - $1,050
-55 Reduced 19.71%
224 $3,000
Q2 2018

Aug 14, 2018

BUY
$10.35 - $16.45 $2,887 - $4,589
279 New
279 $4,000

Others Institutions Holding CDXS

About CODEXIS, INC.


  • Ticker CDXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,494,100
  • Market Cap $108M
  • Description
  • Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
More about CDXS
Track This Portfolio

Track Valeo Financial Advisors, LLC Portfolio

Follow Valeo Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Valeo Financial Advisors, LLC with notifications on news.